Redeye: EG7 - Solid quarter and stable outlook
Redeye updates on EG7 post its Q2-results which came in close to our expectations. The company reiterates its guidance for 2023 and we make limited changes to our estimates while awaiting an update on the company’s long-term strategy at its CMD due on September 20.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/